Christopher Seder to Combined Modality Therapy
This is a "connection" page, showing publications Christopher Seder has written about Combined Modality Therapy.
Connection Strength
0.674
-
Reply to "Letter to the editor of Annals of Surgical Oncology Concerning " The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer" by Sunil Kumar et al. Ann Surg Oncol. 2021 06; 28(6):3433-3434.
Score: 0.169
-
The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer. Ann Surg Oncol. 2020 Aug; 27(8):3030-3036.
Score: 0.163
-
Variation in Pulmonary Resection Practices Between The Society of Thoracic Surgeons and the European Society of Thoracic Surgeons General Thoracic Surgery Databases. Ann Thorac Surg. 2016 Jun; 101(6):2077-84.
Score: 0.123
-
Four Synchronous Primary Malignancies of the Breast, Lung, Colon and Esophagus. Anticancer Res. 2015 Nov; 35(11):6159-62.
Score: 0.119
-
Stage IIIA non-small cell lung cancer: morbidity and mortality of three distinct multimodality regimens. Ann Thorac Surg. 2013 May; 95(5):1708-16.
Score: 0.100